Global Rho Associated Protein Kinase 2 Market Growth 2019-2024

Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.
In the last several years, global market of Rho Associated Protein Kinase 2 developed rapidly, with an average growth rate of 68%. In 2017, Global Market Size of Rho Associated Protein Kinase 2 is nearly 850 K USD.
For developing product, there are 1 product in Phase 3, 2 products in Phase 2, 0 products in Phase 1 and 6 products in Preclinical. The total investment for Rho Associated Protein Kinase 2 developing is around 88 M USD in 2017.
The Application of Rho Associated Protein Kinase 2 includes Glaucoma, Spinal Cord, Chronic Obstructive Pulmonary Disease, Immune Therapy and Others, and the proportion of R&D Investmen for Glaucoma in 2017 is about 67%, and the proportion is in decrease trend from 2012 to 2016.

According to this study, over the next five years the Rho Associated Protein Kinase 2 market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rho Associated Protein Kinase 2 business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Rho Associated Protein Kinase 2 market by product type, application, key manufacturers and key regions and countries.

This study considers the Rho Associated Protein Kinase 2 value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Glaucoma
Spinal Cord
Chronic Obstructive Pulmonary Disease
Immune Therapy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Aerie Pharmaceuticals
Kadmon Corporation
BioAxone BioSciences Inc
Redx Pharma
Angion Biomedica
DWTI
HitGen LTD
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Rho Associated Protein Kinase 2 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rho Associated Protein Kinase 2 market by identifying its various subsegments.
Focuses on the key global Rho Associated Protein Kinase 2 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rho Associated Protein Kinase 2 with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rho Associated Protein Kinase 2 submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.